Literature DB >> 15452664

Visual estimation of the global myocardial extent of hyperenhancement on delayed contrast-enhanced MRI.

Alexandre Comte1, Alain Lalande, Paul M Walker, Alexandre Cochet, Louis Legrand, Yves Cottin, Jean-Eric Wolf, François Brunotte.   

Abstract

MRI with paramagnetic contrast agent allows the assessment of the extent of myocardial tissue injury after infarction. Visual segmental scoring has been widely used to define the transmural extent of myocardial infarction, but no attempt has been made to use visual scores in order to assess the percentage of the whole myocardium infarcted. By summing all the segmental scores using a 17-segment model, a global index of the size of the infarcted myocardium is easily obtained. The entire left ventricle of 60 patients with a recent myocardial infarction was scanned using an ECG-gated gradient echo sequence after injection of gadolinium contrast agent. The global score was defined as the sum of the scores on each segment, and expressed as a percentage of the maximum possible score. This index was compared with a planimetric evaluation of hyperenhancement, expressed as a percentage of the left ventricle myocardial volume. There is a good correlation between the two methods (r=0.91; y=1.06x+0.20), and the Bland-Altman plot shows a high concordance between the two approaches (mean of the differences =1.45%). A visual approach based on a 17-segment model can be used to evaluate the global myocardial extent of the hyperenhancement with similar results to planimetry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452664     DOI: 10.1007/s00330-004-2483-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

Review 1.  Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction.

Authors:  R J Gibbons; T D Miller; T F Christian
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

2.  Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.

Authors:  Christoph Klein; Stephan G Nekolla; Frank M Bengel; Mitsuru Momose; Andrea Sammer; Felix Haas; Bernhard Schnackenburg; Wolfram Delius; Harald Mudra; Dieter Wolfram; Markus Schwaiger
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

Review 3.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

4.  Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging.

Authors:  Heiko Mahrholdt; Anja Wagner; Thomas A Holly; Michael D Elliott; Robert O Bonow; Raymond J Kim; Robert M Judd
Journal:  Circulation       Date:  2002-10-29       Impact factor: 29.690

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

Review 7.  Imaging of ischemic heart disease.

Authors:  Martin J Lipton; Jan Bogaert; Larry M Boxt; Richard C Reba
Journal:  Eur Radiol       Date:  2002-01-11       Impact factor: 5.315

8.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms.

Authors:  J A Lima; R M Judd; A Bazille; S P Schulman; E Atalar; E A Zerhouni
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

9.  Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction.

Authors:  K Ramani; R M Judd; T A Holly; T B Parrish; V H Rigolin; M A Parker; C Callahan; S W Fitzgerald; R O Bonow; F J Klocke
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

10.  Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction.

Authors:  Bernhard L Gerber; Jérôme Garot; David A Bluemke; Kathérine C Wu; João A C Lima
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

View more
  7 in total

1.  Characterization of the peri-infarction zone using T2-weighted MRI and delayed-enhancement MRI in patients with acute myocardial infarction.

Authors:  Alexander Stork; Gunnar K Lund; Kai Muellerleile; Paul M Bansmann; Claus Nolte-Ernsting; Joern Kemper; Philipp G C Begemann; Gerhard Adam
Journal:  Eur Radiol       Date:  2006-04-20       Impact factor: 5.315

2.  Late myocardial enhancement assessed by 64-MSCT in reperfused porcine myocardial infarction: diagnostic accuracy of low-dose CT protocols in comparison with magnetic resonance imaging.

Authors:  H Brodoefel; B Klumpp; A Reimann; M Ohmer; M Fenchel; S Schroeder; S Miller; C Claussen; A F Kopp; A M Scheule
Journal:  Eur Radiol       Date:  2006-06-27       Impact factor: 5.315

3.  Clinical safety of cardiac magnetic resonance imaging at 3 T early after stent placement for acute myocardial infarction.

Authors:  Jérôme Jehl; Alexandre Comte; Sébastien Aubry; Nicolas Meneveau; François Schiele; Bruno Kastler
Journal:  Eur Radiol       Date:  2009-12       Impact factor: 5.315

4.  Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients.

Authors:  Dibya Ranjan Behera; Ajit Kumar V K; Narayanan Namboodiri K K; Sivasankaran S; Krishna Kumar Mohanan Nair; Sanjay G; Kapilamoorthy T R; Arun Gopalakrishnan; Harikrishnan S
Journal:  Indian Heart J       Date:  2020-07-02

5.  The relationship between the severity of coronary artery disease and epicardial adipose tissue depends on the left ventricular function.

Authors:  Christina Doesch; Tim Süselbeck; Dariusch Haghi; Florian Streitner; Stefan O Schoenberg; Martin Borggrefe; Theano Papavassiliu
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

6.  Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction.

Authors:  Alexandre Cochet; Marianne Zeller; Alain Lalande; Isabelle L'huillier; Paul M Walker; Claude Touzery; Bruno Verges; Jean-Eric Wolf; François Brunotte; Yves Cottin
Journal:  J Cardiovasc Magn Reson       Date:  2008-01-15       Impact factor: 5.364

7.  Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.

Authors:  Pauli Pöyhönen; Sari Kivistö; Miia Holmström; Helena Hänninen
Journal:  BMC Cardiovasc Disord       Date:  2014-08-27       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.